ACTD logo

AlzChem Group AGBATS-CHIXE:ACTD Stock Report

Market Cap €1.6b
Share Price
n/a
1Y19.5%
7D0%
1D-6.8%
Portfolio Value
View

AlzChem Group AG

BATS-CHIXE:ACTD Stock Report

Market Cap: €1.6b

AlzChem Group (ACTD) Stock Overview

Develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. More details

ACTD fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

ACTD Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW470,065 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
470,065 investors already sharing narratives

AlzChem Group AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for AlzChem Group
Historical stock prices
Current Share Price€177.05
52 Week High€189.90
52 Week Low€130.80
Beta0.39
1 Month Change0%
3 Month Changen/a
1 Year Change19.55%
3 Year Changen/a
5 Year Changen/a
Change since IPO326.63%

Recent News & Updates

Recent updates

Shareholder Returns

ACTDGB ChemicalsGB Market
7D0%0.5%-0.3%
1Y19.5%24.0%18.3%

Return vs Industry: ACTD underperformed the UK Chemicals industry which returned 25% over the past year.

Return vs Market: ACTD exceeded the UK Market which returned 18.5% over the past year.

Price Volatility

Is ACTD's price volatile compared to industry and market?
ACTD volatility
ACTD Average Weekly Movementn/a
Chemicals Industry Average Movement6.2%
Market Average Movement5.1%
10% most volatile stocks in GB Market10.4%
10% least volatile stocks in GB Market2.7%

Stable Share Price: ACTD's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine ACTD's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19081,680Andreas Niedermaierwww.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries.

AlzChem Group AG Fundamentals Summary

How do AlzChem Group's earnings and revenue compare to its market cap?
ACTD fundamental statistics
Market cap€1.62b
Earnings (TTM)€67.77m
Revenue (TTM)€593.80m
23.9x
P/E Ratio
2.7x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACTD income statement (TTM)
Revenue€593.80m
Cost of Revenue€204.09m
Gross Profit€389.71m
Other Expenses€321.94m
Earnings€67.77m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Oct 29, 2026

Earnings per share (EPS)6.69
Gross Margin65.63%
Net Profit Margin11.41%
Debt/Equity Ratio32.4%

How did ACTD perform over the long term?

See historical performance and comparison

Dividends

1.3%
Current Dividend Yield
31%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/13 18:30
End of Day Share Price 2026/06/30 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AlzChem Group AG is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gerhard OrgonasBerenberg
Julia WinckelmannBofA Global Research
Manuela StuerzerDeutsche Bank